BK VAX LIMITED

Active Altrincham

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
B

BK VAX LIMITED

Research and experimental development on biotechnology

Founded 16 Jun 2021 Active Altrincham, England 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

LIPTIDE LIMITED 16 Jun 2021 — 29 Jun 2021
Accounts Submitted 24 Jun 2025 Next due 30 Jun 2026 1 month remaining
Confirmation Submitted 18 Jun 2025 Next due 29 Jun 2026 1 month remaining
Net assets £-132K £0 2024 year on year
Total assets £79K £1 2024 year on year
Total Liabilities £210K £1 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Hamilton House Church Street Altrincham WA14 4DR England

Full company profile for BK VAX LIMITED (13460322), an active company based in Altrincham, England. Incorporated 16 Jun 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2024
Type micro-entity
Next accounts 30 Sept 2025
Due by 30 Jun 2026 1 month remaining

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

N/A

Net Assets

-£131.66k

Total Liabilities

£210.28k

Increased by £1.00 (+0%)

Turnover

N/A

Employees

N/A

Debt Ratio

267%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
30 Sept Year End
2023
30 Sept Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 9,900 Shares £99 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 Aug 20211,500£15£0.01
31 Aug 20218,400£84£0.01

Officers

Officers

1 active 2 resigned
Status
Jordan Robert KennedyDirectorBritishEngland3412 Dec 2024Active

Shareholders

Shareholders (2)

Pp Vaccine Limited
85.0%
Ryboquin Company Ltd
10.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Pp Vaccine Limited

United Kingdom

Active
Notified 31 Aug 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Brian George Kennedy

Ceased 28 May 2025

Ceased

Group Structure

Group Structure

BK VAX LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Apr 2026OfficersTermination of Brian George Kennedy as director on 26 Mar 2026
24 Jun 2025AccountsAnnual accounts made up to 30 Sept 2024
18 Jun 2025Confirmation StatementConfirmation statement made on 15 Jun 2025 with no updates
4 Jun 2025OfficersChange to director Mr Jordan Robert Kennedy on 4 Jun 2025
29 May 2025Confirmation StatementSecond Filing Of Confirmation Statement With Made Up Date
10 Apr 2026 Officers

Termination of Brian George Kennedy as director on 26 Mar 2026

24 Jun 2025 Accounts

Annual accounts made up to 30 Sept 2024

18 Jun 2025 Confirmation Statement

Confirmation statement made on 15 Jun 2025 with no updates

4 Jun 2025 Officers

Change to director Mr Jordan Robert Kennedy on 4 Jun 2025

29 May 2025 Confirmation Statement

Second Filing Of Confirmation Statement With Made Up Date

Recent Activity

Latest Activity

Termination of Brian George Kennedy as director on 26 Mar 2026

1 months ago on 10 Apr 2026

Annual accounts made up to 30 Sept 2024

11 months ago on 24 Jun 2025

Confirmation statement made on 15 Jun 2025 with no updates

11 months ago on 18 Jun 2025

Change to director Mr Jordan Robert Kennedy on 4 Jun 2025

11 months ago on 4 Jun 2025

Second Filing Of Confirmation Statement With Made Up Date

11 months ago on 29 May 2025